Monoamines' role in islet cell function and type 2 diabetes risk

被引:5
|
作者
Roberts, Fiona Louise [1 ]
Cataldo, Luis Rodrigo [1 ,2 ]
Fex, Malin [1 ]
机构
[1] Lund Univ, Diabet Ctr, Dept Clin Sci, Unit Mol Metab, SE-21428 Malmo, Sweden
[2] Univ Copenhagen, Novo Nord Fdn Ctr Basic Metab Res, Fac Hlth & Med Sci, DK-2200 Copenhagen, Denmark
基金
瑞典研究理事会;
关键词
PANCREATIC BETA-CELLS; SEROTONIN REUPTAKE INHIBITORS; STIMULATED INSULIN-SECRETION; FASTING PLASMA-GLUCOSE; SELECTIVE SEROTONIN; MELATONIN RECEPTORS; GLUCAGON-SECRETION; ENDOCRINE PANCREAS; GENE-EXPRESSION; MTNR1B;
D O I
10.1016/j.molmed.2023.08.009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The two monoamines serotonin and melatonin have recently been highlighted as potent regulators of islet hormone secretion and overall glucose homeostasis in the body. In fact, dysregulated signaling of both amines are implicated in (3-cell dysfunction and development of type 2 diabetes mellitus (T2DM). Serotonin is a key player in (3-cell physiology and plays a role in expansion of (3-cell mass. Melatonin regulates circadian rhythm and nutrient metabolism and reduces insu-lin release in human and rodent islets in vitro. Herein, we focus on the role of se-rotonin and melatonin in islet physiology and the pathophysiology of T2DM. This includes effects on hormone secretion, receptor expression, genetic variants influencing (3-cell function, melatonin treatment, and compounds that alter sero-tonin availability and signaling.
引用
收藏
页码:1045 / 1058
页数:14
相关论文
共 50 条
  • [31] Effect of exenatide on β cell function after islet transplantation in type 1 diabetes
    Al Ghofaili, Khalid
    Fung, Michelle
    Ao, Ziliang
    Meloche, Mark
    Shapiro, R. Jean
    Warnock, Garth L.
    Elahi, Darlush
    Meneilly, Graydon S.
    Thompson, David M.
    TRANSPLANTATION, 2007, 83 (01) : 24 - 28
  • [32] Relationship between circadian blood pressure variability and function of islet α and β cell in type 2 diabetes with dyssomnia
    Ren, Hui-Zhu
    Zheng, Miao-Yan
    Shan, Chun-Yan
    Yang, Ju-Hong
    Xu, Yan-Guang
    Yang, Yan-Hui
    Wang, Ying
    Chen, Li-Ming
    Chang, Bao-Cheng
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2015, 29 (05) : 675 - 678
  • [33] Elevated proinsulin but not islet amyloid polypeptide accompanies declining β-cell function in type 2 diabetes.
    McNamara, CM
    Clark, A
    Turner, RC
    DIABETOLOGIA, 1998, 41 : A169 - A169
  • [34] β-Cell Mass Dynamics and Islet Cell Plasticity in Human Type 2 Diabetes
    Hanley, Stephen C.
    Austin, Emily
    Assouline-Thomas, Beatrice
    Kapeluto, Jordanna
    Blaichman, Jason
    Moosavi, Mandana
    Petropavlovskaia, Maria
    Rosenberg, Lawrence
    ENDOCRINOLOGY, 2010, 151 (04) : 1462 - 1472
  • [35] Role of islet amyloid in type 2 diabetes mellitus:: consequence or cause?
    Höppener, JWM
    Nieuwenhuis, MG
    Vroom, TM
    Ahrén, B
    Lips, CJM
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2002, 197 (1-2) : 205 - 212
  • [36] Exercise and inactivity as modifiers of b cell function and type 2 diabetes risk
    Hall, Liam G.
    Thyfault, John P.
    Johnson, James D.
    JOURNAL OF APPLIED PHYSIOLOGY, 2023, 134 (04) : 823 - 839
  • [37] Islet inflammation in type 2 diabetes
    Piero Marchetti
    Diabetologia, 2016, 59 : 668 - 672
  • [38] Dual role of interleukin-1β in islet amyloid formation and its β-cell toxicity: Implications for type 2 diabetes and islet transplantation
    Park, Yoo Jin
    Warnock, Garth L.
    Ao, Ziliang
    Safikhan, Nooshin
    Meloche, Mark
    Asadi, Ali
    Kieffer, Timothy J.
    Marzban, Lucy
    DIABETES OBESITY & METABOLISM, 2017, 19 (05): : 682 - 694
  • [39] Islet inflammation in type 2 diabetes
    Marchetti, Piero
    DIABETOLOGIA, 2016, 59 (04) : 668 - 672
  • [40] DNase I aggravates islet -cell apoptosis in type 2 diabetes
    Zhu, Bin
    Zhang, Lei
    Zhang, Yue-Ying
    Wang, Lei
    Li, Xin-Gang
    Liu, Teng
    Fu, Yu-Ke
    Zheng, Yan-Fei
    Li, Ping
    Zhao, Zhi-Gang
    MOLECULAR MEDICINE REPORTS, 2016, 13 (06) : 4577 - 4584